{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:15:13Z","timestamp":1788308113057,"version":"build-2803163510"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to compare cumulative [fresh and frozen embryo transfers from one ovarian stimulation (OS) cycle] pregnancy and live birth rates in women for whom the choice between recombinant FSH (rFSH) and urinary FSH (uFSH) for OS was linked to FSH receptor (FSHR) N680S genotype and compared these to non-genotyped controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To define the optimal combination of FSH type and FSHR genotype, 475 women were allocated to either the rFSH group or to the uFSH group for OS. The number of aspirated oocytes, cumulative pregnancy rates, and live birth rates in the first OS cycle were determined. Subsequently, their FSHR N680S (rs6166) variant was analyzed. Clinical data were backed up by\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments, in which COS-1 cells were transfected with homozygous FSHR variants and stimulated with either uFSH or rFSH. cAMP was measured to evaluate receptor activity. Thereafter, a sub-cohort of 221 who received optimal FSH treatment in relation to their FSHR genotype was selected from the total cohort of 475 women. Cumulative pregnancy and live birth rates were compared between 991 non-genotyped controls and these 221 women. Binary logistic regression was used to explore the odds ratios (ORs) and 95% confidence intervals (CIs) for cumulative pregnancy and live birth rates in the first OS cycle among genotyped and optimally treated women, with the non-genotyped cohort set as the reference. Adjustment was made for age, body mass index, and method of fertilization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The combined clinical and\n                      <jats:italic>in vitro<\/jats:italic>\n                      data indicated that uFSH was the optimal choice for FSHR N680S S-allele carriers, whereas rFSH was the hormone of choice for asparagine (NN) subjects. The sub-cohort consisting of uFSH-treated S-carriers together with rFSH-treated NN-carriers had a significantly higher chance of pregnancy (51% vs. 40%; OR: 1.40, 95% CI 1.12-1.75, p=0.003) and live birth (40% vs. 29%; OR: 1.55, 95% CI 1.23-1.96, p&amp;lt;0.001) compared to non-genotyped women, in whom the choice of hormone was based on a standard clinical evaluation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A significantly increased chance of pregnancy and live birth can be achieved by a genotype-guided approach. While the administration of uFSH should be the choice for S-carriers, rFSH is beneficial for NN-carrying women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1576090","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T01:28:54Z","timestamp":1747099734000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["FSH receptor N680S genotype-guided gonadotropin choice increases cumulative pregnancy and live birth rates after in vitro fertilization"],"prefix":"10.3389","volume":"16","author":[{"given":"Ida","family":"Hjelm\u00e9r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilda","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emir","family":"Henic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"J\u0119drzejczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Nenonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Ozegowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Giwercman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta Laczna","family":"Kitlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne Lundberg","family":"Giwercman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"B1","volume-title":"International Classification of Diseases, 11th Revision (Icd-11)","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001356","article-title":"National,\u00a0regional, and global trends in infertility prevalence since 1990: A systematic analysis of 277 health surveys","volume":"9","author":"Mascarenhas","year":"2012","journal-title":"PLoS Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem046","article-title":"International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care","volume":"22","author":"Boivin","year":"2007","journal-title":"Hum Reprod"},{"key":"B4","volume-title":"Infecundity Infertility and Childlessness in Developing Countries","author":"Rutstein","year":"2004"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00114","article-title":"Efficacy of follicle-stimulating hormone (Fsh) alone, Fsh\u2009+\u2009Luteinizing hormone, human menopausal gonadotropin or Fsh\u2009+\u2009Human chorionic gonadotropin on assisted reproductive technology outcomes in the \"Personalized\" Medicine era: A meta-analysis","volume":"8","author":"Santi","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/humupd\/dmy019","article-title":"Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: A systematic review and meta-analysis","volume":"24","author":"Alviggi","year":"2018","journal-title":"Hum Reprod Update"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab068","article-title":"The effect of polymorphisms in Fshr and Fshb genes on ovarian response: A prospective multicenter multinational study in Europe and Asia","volume":"36","author":"Polyzos","year":"2021","journal-title":"Hum Reprod"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/fpc.0000000000000374","article-title":"The N680s variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation","volume":"29","author":"Nenonen","year":"2019","journal-title":"Pharmacogenet Genomics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32835fe813","article-title":"Effect of follicle-stimulating hormone receptor N680s polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response","volume":"23","author":"Lledo","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/fpc.0000000000000215","article-title":"Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype","volume":"26","author":"Lled\u00f3","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s1472-6483(10)62135-9","article-title":"Fsh isoform composition of commercial gonadotrophin preparations: A neglected aspect","volume":"9","author":"Andersen","year":"2004","journal-title":"Reprod BioMed Online"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-006-0005-5","article-title":"Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for Ivf-Et","volume":"51","author":"Jun","year":"2006","journal-title":"J Hum Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/RBI.S7362","article-title":"What is the clinical relevance of follicle-stimulating hormone isoforms in fertility treatment","volume":"4","author":"Andersen","year":"2011","journal-title":"Reprod Biol Insights"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.5.1160","article-title":"Biological characterization of recombinant human follicle stimulating hormone isoforms","volume":"14","author":"D'Antonio","year":"1999","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod59.4.854","article-title":"Isoforms of human recombinant follicle-stimulating hormone: comparison of effects on murine follicle development in vitro","volume":"59","author":"Vitt","year":"1998","journal-title":"Biol Reprod"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.1.8601","article-title":"Acidic mix of Fsh isoforms are better facilitators of ovarian follicular maturation and E2 production than the less acidic","volume":"143","author":"West","year":"2002","journal-title":"Endocrinology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"Cd005354","DOI":"10.1002\/14651858.CD005354.pub2","article-title":"Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles","volume":"2011","author":"van Wely","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B18","volume-title":"R: A Language and Environment for Statistical Computing","year":"2022"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2010.02.004","article-title":"Frequency distribution of polymorphisms in the Fsh receptor gene in infertility patients of different ethnicity","volume":"20","author":"Kuijper","year":"2010","journal-title":"Reprod BioMed Online"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)67424-7","article-title":"Genetic association studies","volume":"366","author":"Cordell","year":"2005","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dez017","article-title":"Are interventions in reproductive medicine assessed for plausible and clinically relevant effects? A systematic review of power and precision in trials and meta-analyses","volume":"34","author":"Stocking","year":"2019","journal-title":"Hum Reprod"},{"key":"B22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.rbmo.2020.10.008","article-title":"Is There an Optimal Number of Oocytes Retrieved at Which Live Birth Rates or Cumulative Live Birth Rates Per Aspiration Are Maximized after Art? A Systematic Review","volume":"42","author":"Law","year":"2021","journal-title":"Reprod BioMed Online"},{"key":"B23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mce.2014.06.013","article-title":"Fshr polymorphism P.N680s mediates different responses to Fsh in vitro","volume":"393","author":"Casarini","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.9.6789","article-title":"Ovarian response to follicle-stimulating hormone (Fsh) stimulation depends on the Fsh receptor genotype","volume":"85","author":"Perez Mayorga","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2268","article-title":"A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle","volume":"90","author":"Greb","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.01.003","article-title":"Recombinant luteinizing hormone supplementation in assisted reproductive technology: A systematic review","volume":"109","author":"Alviggi","year":"2018","journal-title":"Fertil Steril"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.22074\/ijfs.2015.4178","article-title":"Efficacy of highly purified urinary Fsh versus recombinant Fsh in Chinese women over 37 years undergoing assisted reproductive techniques","volume":"8","author":"Liu","year":"2015","journal-title":"Int J Fertil Steril"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.11.003","article-title":"How do infertile couples choose their Ivf centers? An internet-based survey","volume":"83","author":"Marcus","year":"2005","journal-title":"Fertil Steril"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead265","article-title":"Applying a simplified economic evaluation approach to evaluate infertility treatments in clinical practice","volume":"39","author":"Feng","year":"2024","journal-title":"Hum Reprod"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab155","article-title":"A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian Ivf\/Icsi patients","volume":"36","author":"Qiao","year":"2021","journal-title":"Hum Reprod"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.08.112","article-title":"Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference","volume":"91","author":"Orvieto","year":"2009","journal-title":"Fertil Steril"},{"key":"B32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12958-022-01016-y","article-title":"Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization \/intracytoplasmic sperm injection","volume":"20","author":"Yang","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.rbmo.2017.03.021","article-title":"A randomized controlled trial comparing the efficacy and safety of two Hmg preparations gaining their Lh bioactivity from different Hcg sources","volume":"35","author":"Lockwood","year":"2017","journal-title":"Reprod BioMed Online"},{"key":"B34","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1530\/eje-13-0624","article-title":"Mechanisms in endocrinology: genetics of Fsh action: A 2014-and-beyond view","volume":"170","author":"Simoni","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148314","article-title":"Association of Fshr gene polymorphisms with poor ovarian response in patients undergoing Ivf: A systematic review and meta-analysis","volume":"909","author":"Hu","year":"2024","journal-title":"Gene"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1576090\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T01:28:57Z","timestamp":1747099737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1576090\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":35,"alternative-id":["10.3389\/fendo.2025.1576090"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1576090","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"article-number":"1576090"}}